Jonathan Knikman

7PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMedical biochemistry - nucleic acids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

|Aug 15, 2024
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.

Jonathan E Knikman, Qinglian Zhai, Carin A T C Lunenburg

|Nov 13, 2023
A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens.

Jonathan E Knikman, Marta Lopez-Yurda, Didier Meulendijks

|Aug 28, 2023
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis.

Jonathan E Knikman, Tycho A Wilting, Marta Lopez-Yurda

|Mar 11, 2023
Assay performance and stability of uracil and dihydrouracil in clinical practice.

Jonathan E Knikman, Hilde Rosing, Henk-Jan Guchelaar

|Nov 07, 2019
A review of the bioanalytical methods for the quantitative determination of capecitabine and its metabolites in biological matrices.

Jonathan E Knikman, Hilde Rosing, Henk-Jan Guchelaar

Pageof 2

Frequent Collaborators

4 joint publications

Henk-Jan Guchelaar

3 joint publications

Ron H J Mathijssen

3 joint publications

Jesse J Swen

3 joint publications

Hans Gelderblom